"Fluorodeoxyglucose F18" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
The compound is given by intravenous injection to do POSITRON-EMISSION TOMOGRAPHY for the assessment of cerebral and myocardial glucose metabolism in various physiological or pathological states including stroke and myocardial ischemia. It is also employed for the detection of malignant tumors including those of the brain, liver, and thyroid gland. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1162)
Concept/Terms
Fluorodeoxyglucose F18- Fluorodeoxyglucose F18
- F18, Fluorodeoxyglucose
- 18F-FDG
- Fluorodeoxyglucose F 18
- F 18, Fluorodeoxyglucose
- Fludeoxyglucose F 18
- F 18, Fludeoxyglucose
- Fluorine-18-fluorodeoxyglucose
- Fluorine 18 fluorodeoxyglucose
- 18F Fluorodeoxyglucose
- Fluorodeoxyglucose, 18F
- 18FDG
Below are MeSH descriptors whose meaning is more general than "Fluorodeoxyglucose F18".
Below are MeSH descriptors whose meaning is more specific than "Fluorodeoxyglucose F18".
This graph shows the total number of publications written about "Fluorodeoxyglucose F18" by people in Harvard Catalyst Profiles by year, and whether "Fluorodeoxyglucose F18" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 5 | 5 |
| 1994 | 0 | 5 | 5 |
| 1995 | 0 | 9 | 9 |
| 1996 | 0 | 5 | 5 |
| 1997 | 1 | 11 | 12 |
| 1998 | 7 | 2 | 9 |
| 1999 | 5 | 5 | 10 |
| 2000 | 4 | 6 | 10 |
| 2001 | 5 | 6 | 11 |
| 2002 | 7 | 7 | 14 |
| 2003 | 7 | 9 | 16 |
| 2004 | 12 | 14 | 26 |
| 2005 | 11 | 9 | 20 |
| 2006 | 10 | 13 | 23 |
| 2007 | 24 | 15 | 39 |
| 2008 | 19 | 23 | 42 |
| 2009 | 27 | 24 | 51 |
| 2010 | 15 | 28 | 43 |
| 2011 | 31 | 25 | 56 |
| 2012 | 18 | 34 | 52 |
| 2013 | 39 | 35 | 74 |
| 2014 | 32 | 43 | 75 |
| 2015 | 21 | 31 | 52 |
| 2016 | 20 | 35 | 55 |
| 2017 | 14 | 29 | 43 |
| 2018 | 16 | 41 | 57 |
| 2019 | 17 | 30 | 47 |
| 2020 | 16 | 29 | 45 |
| 2021 | 18 | 34 | 52 |
| 2022 | 11 | 28 | 39 |
| 2023 | 2 | 11 | 13 |
Below are the most recent publications written about "Fluorodeoxyglucose F18" by people in Profiles.
-
The 2023 Duke-International Society for Cardiovascular Infectious Diseases Criteria for Infective Endocarditis: Updating the Modified Duke Criteria. Clin Infect Dis. 2023 08 22; 77(4):518-526.
-
Amygdalar activity measured using FDG-PET/CT at head and neck cancer staging independently predicts survival. PLoS One. 2023; 18(8):e0279235.
-
Understanding the Value of FAPI versus FDG PET/CT in Primary and Metastatic Lung Cancer. Radiology. 2023 08; 308(2):e231768.
-
Psychological stress is associated with arterial inflammation in people living with treated HIV infection. Brain Behav Immun. 2023 10; 113:21-28.
-
Worsening of lung perfusion to tissue density distributions during early acute lung injury. J Appl Physiol (1985). 2023 Aug 01; 135(2):239-250.
-
Whole-brain analyses indicate the impairment of posterior integration and thalamo-frontotemporal broadcasting in disorders of consciousness. Hum Brain Mapp. 2023 08 01; 44(11):4352-4371.
-
COVID-19: Findings in nuclear medicine from head to toe. Clin Imaging. 2023 Jul; 99:10-18.
-
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy. Int J Radiat Oncol Biol Phys. 2023 08 01; 116(5):1025-1030.
-
Radionuclide Assessment of Sarcoidosis. Cardiol Clin. 2023 May; 41(2):207-215.
-
Somatostatin Receptor 2-Targeted PET Radiotracers Shine in Assessing Inflammatory Activity in Large Vessel Vasculitis. J Am Coll Cardiol. 2023 01 31; 81(4):355-357.